Decreased expression of T-cell NF-κB p65 subunit in steroid-resistant nephrotic syndrome

Kidney International

Volumn 66, Issue 1, 2004, Pages 60-67

  Aviles, Diego H ^a,b   Vehaskari, V Matti ^a   Manning, Jennifer ^a   Ochoa, Augusto C ^a   Zea, Arnold H ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Nephrotic syndrome; NF B; Steroid resistance; T lymphocytes

Indexed keywords

CYCLOSPORIN; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOKINE; MESSENGER RNA; PREDNISONE; PROTEIN P50; PROTEIN SUBUNIT; STEROID; SYNAPTOTAGMIN; TACROLIMUS; TRANSCRIPTION FACTOR AP 1;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 3042845734     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00706.x     Document Type: Article

References (38)

1. WARADY BA, HEBERT D, SULLIVAN EK, et al: Renal transplantation, chronic dialysis, and chronic renal failure in children and adolescents. The 1995 Annual Report of the North American Pediatrics Renal transplant Cooperative Study. Pediatr Nephrol 11:49-54, 1997
2. BONILLA-FELIX M, PARRA C, DAJANI T, et al: Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int 55:1885-1890, 1999
3. NISHIMURA M, TOKI J, SUGIURA K, et al: Focal segmental sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder. J Exp Med 179:1053-1058, 1994
4. MARKOVIC-LIPPKOVSKI J, MULLER CA, RISLER T, et al: Mononuclear leukocytes, expression of HLA class II antigen and intercellular adhesion molecule 1 in focal segmental glomerulosclerosis. Nephron 59:286-293, 1991
5. HEROLD HG, STAPLETON FB, TROURY RL, et al: Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome. Clin Exp Immunol 52:581-585, 1983
6. HULTON SA, SHAH V, BYRNE MR, et al: Lymphocyte subpopulation, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8:135-139, 1994
7. SHALHOUB RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2:556-560, 1974
8. DANIEL V, TRAUTMANN Y, KONRAD M, et al: T lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 47:289-297, 1997
9. HESLAN JM, BRANELEC AI, PILATTE Y, et al: Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal change nephrotic syndrome. Clin Exp Immunol 86:157-162, 1991
10. SCHNAPER HW, ACNE TM: Steroid-sensitive mechanism of soluble immune response suppressor production in steroid responsive nephrotic syndrome. J Clin Invest 79:257-264, 1987
11. CHEONG HI, WON HAN H, WON PARK H, et al: Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 15:78-81, 2000
12. ARTERO ML, SHARMA R, SAVIN VJ, et al: Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574-581, 1994
13. AVILES DH, IRWIN KC, VEHASKARI VM, et al: Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 13:298-300, 1999
14. MENDOZA SA, REZNICK VM, GRISWOLD WR, et al: Treatment of steroid resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4:303-307, 1990
15. KAM J, SZEFLER S, SURS W, et al: Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T-cell response to glucocorticoids. J Immunol 151:3460-3466, 1993
16. WALKER KB, POTTER JM, HOUSE AK: Interleukin 2 synthesis in the presence of steroids: A model for steroid resistance. Clin Exp Immunol 68:162-167, 1987
17. BARNES PJ: Molecular mechanism of steroid action in asthma. J Allergy Clin Immunol 97:159-168, 1996
18. ADCOCK IM, LANE SJ, BROWN CR, et al: Abnormal glucocorticoid receptor-activator protein1 interaction in steroid-resistant asthma. J Exp Med 182:1951-1958, 1995
19. GARG A, AGGARWAL BB: Nuclear transcription factor-kappa B as a target for cancer drug development. Leukemia 16:1053-1068, 2002
20. TUCKERMAN JP, REICHART HM, ARRIBAS R, et al: The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1 dependent genes in the skin. J Cell Biol 147:1365-1379, 1999
21. AITTOM-KI S, PESU M, GRONER B, et al: Cooperation among stat-1, glucocorticoid receptor and pu1 in transcriptional activation of the high-affinity FC γ receptor I in monocytes. J Immunol 164:5689-5697, 2000
22. RAY A, PREFONTAINE KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappaB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756, 1994
23. ZEA AH, OCHOA MT, GHOSH P, et al: Changes in expression of signal transduction proteins in lymphocytes of patients with leprosy. Infect Immun 16:499-504, 1998
24. TAHERI F, OCHOA JB, FAGHIRI Z, et al: L-Arginine regulates the expression of T-cell receptor zeta chain (CD3-Zeta) in Jurkat cells. Clin Cancer Res 7(Suppl 3):958-965, 2001
25. RICE N, MACKICHAN ML, ISRAEL A: The precursor of NF-κB p50 has IκB-like functions. Cell 71:243-253, 1992
26. MANNING J, BEUTLER K, KNEPPER M, et al: Upregulation of renal BSC1 and TSC in prenataly programmed hypertension. Am J Physiol Renal Physiol 283:F202-F206, 2001
27. BAEUERLE PA, BALTIMORE D: NF-κB. Ten years later. Cell 87:13-20, 1996
28. TAM WF, WANG W, SEN R: Cell specific association and shuttling of IkappaBalpha provide mechanism for nuclear NF-kappaB in B lymphocytes. Mol Cell Biol 21:4837-4846, 2001
29. AYROLDI E, MIGLIORATI G, BRUSCOLI S, et al: Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood 98:743-753, 2001
30. BAEURLE PA, HENKEL T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994
31. MCKAY LI, CIDLOWSKI JA: Cross-Talk between nuclear factor-κB and the steroid hormone receptors; mechanism of mutual antagonism. Mol Endo 12:45-56, 1998
32. CAO C, LU S, DONG C, et al: Abnormal DNA binding of transcription factors in minimal change nephrotic syndrome. Pediatr Nephrol 16:790-795, 2002
33. LAMA G, LUONGO I, TIRINO G, et al: T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 40:873-874, 2002
34. ZACHWIEJA J, BOBKOWSKI A, DOBROWOLSKA-ZACHWIEJA A, et al: Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome. Pediatr Nephrol 17:733-740, 2002
35. HESLAND JM, BRANELLEC AI, LANG P, et al: Recombinant IL-2 induced proteinuria fact or artifact? Nephron 57:373-374, 1991
36. HISINAGA S, KAWAGOE H, YAMAMOTO Y, et al: Nephrotic syndrome associated with recombinant interleukin-2. Nephron 54:140-146, 1990
37. WONG H, KAMMER G, DENNIS G, et al: Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythrematosus is associated with decreased p65-RelA protein expression. J Immunol 163:1682-1689, 1999
38. SICA A, TAN TH, RICE N, et al: The c-Rel protooncogene product c-Rel but not NF-κB binds to the intronic region of the human interferon gamma gene at the site related to an interferon-stimulable response element. Proc Natl Acad Sci USA 89:1740-1744, 1992